Relationship of Apolipoprotein B-100 and Lipid Profile Parameters among Diabetic Patients in a Tertiary Hospital in Nigeria | Chapter 06 | Current Trends in Disease and Health Vol. 2
Diabetic dyslipidaemia is the bane of
most complications seen in diabetes mellitus. The aim of our study is to
determine the levels of apolipoprotein B-100 among diabetic adults and
non-diabetic control; and its relationship with the traditional lipid profile
parameters.
A total of 58 subjects including 30 diabetic patients and 28 non-diabetic
controls selected from diabetic clinic and immunization centres respectively.
Subjects were randomly selected, examined clinically and have their
anthropometric parameters measured. Lipid profile was assayed using standard
enzymatic spectrophotometric methods while serum apolipoprotein B-100 was
measured using sandwich immunoassay technique. Data were expressed in means and
standard deviations. Differences in means between the two groups were assessed
using Student T-test and relationships tested using Pearson’s correlation
study. Mean ages of diabetic and non-diabetic groups were 57.7±7.4 and 49.3±
17.9 years respectively (p>0.05). Statistical differences exist in the age,
weight, BMI, and blood pressure between the two study groups. Serum
apolipoprotein B-100 in the diabetic and non-diabetic controls were 84.9±58.8
and 67.6±44.3 mg/dl respectively (p<0.05). A weak positive correlation
exists between serum apolipoprotein B-100 and haemoglobin A1c (r=0.420;
p=0.021) while a strong positive correlation exists between apolipoprotein
B-100 and LDL-cholesterol (r=0.702, p=0.001); apolipoprotein B-100 and
non-HDL-cholesterol (r=0.690; p=0.001) and apolipoprotein B-100 and total
cholesterol (r=0.688; p=0.001). Elevated
apolipoprotein B-100 is a biochemical feature in poorly controlled diabetes
mellitus. There is a positive relationship between apolipoprotein B-100 and
total cholesterol, LDL-cholesterol and nonHDL-cholesterol. We advise the adoption
of apolipoprotein B-100 as a routine test in the evaluation of diabetic
dyslipidaemia among the diabetic patients.
Author(s) Details
Dr. Tomisin Matthew Adaja
Department of Chemical
Pathology, University of Medical Sciences, Laje Campus, Ondo City, Ondo State,
Nigeria.
Dr. Matilda Adesuwa O. Ojo
Department of Haematology
and Blood Transfusion, University of Medical Sciences, Laje Campus, Ondo City,
Ondo State, Nigeria.
Dr. Clarisee Noel Ayina
Ayina
University of Douala,
Department of Biology of Animal Organisms, Douala, Cameroon.
Comments
Post a Comment